Press "Enter" to skip to content

Global Plasma Defends Safety & Efficacy of Needlepoint Bipolar Ionization (NPBI®) Technology in Garner Class Action Proceeding

Global Plasma Solutions Inc., says its marketing materials describing NBPI technology as safe and effective is true, accurate and within the bounds of the law. “NPBI technology does not produce harmful byproducts,” GPS says in response to Robert S. Garner’s allegation to the contrary. In its Answer filed in the U.S. District Court for the…

This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.